Not trying to be harsh Storm, really concerned they will cut a deal for the sake of cutting a deal thats not in CYP's favour. The MD keeps backing himself into a corner needlessly and the Chairman has to keep on top of it.
Clinical data in the Phase 1 should show how brilliant the science is for regenerative medicine. The Data with a stronger balance sheet would do wonders for the MD's negotiating position, even if it means a little short term pain.
The Science is whats going to make the Big upside here, lets hope the MD doesn't give it away to appease the pressure from the market.
Not trying to be harsh Storm, really concerned they will cut a...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |